Your browser doesn't support javascript.
loading
Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib.
Prokoph, Nina; Matthews, Jamie D; Trigg, Ricky M; Montes-Mojarro, Ivonne A; Burke, G A Amos; Fend, Falko; Merkel, Olaf; Kenner, Lukas; Geoerger, Birgit; Johnston, Robert; Murray, Matthew J; Riguad, Charlotte; Brugières, Laurence; Turner, Suzanne D.
Afiliación
  • Prokoph N; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Matthews JD; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Trigg RM; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Montes-Mojarro IA; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, University Hospital Tübingen, Eberhard-Karls-University, Tübingen, Germany.
  • Burke GAA; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Fend F; Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, University Hospital Tübingen, Eberhard-Karls-University, Tübingen, Germany.
  • Merkel O; Department of Experimental Pathology and Laboratory Animal Pathology, Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria.
  • Kenner L; Department of Experimental Pathology and Laboratory Animal Pathology, Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria.
  • Geoerger B; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria.
  • Johnston R; Christian Doppler Laboratory for Applied Metabolomics, Medical University of Vienna, Vienna, Austria.
  • Murray MJ; Center for Biomarker Research in Medicine (CBmed) Vienna, Core-Lab2, Medical University of Vienna, Vienna, Austria.
  • Riguad C; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, Villejuif, France.
  • Brugières L; INSERM U1015, Gustave Roussy Cancer Center, Université Paris-Saclay, Villejuif, France.
  • Turner SD; Department of Paediatric Oncology/Haematology, Royal Belfast Hospital for Sick Children, Belfast, UK.
Br J Haematol ; 202(5): 985-994, 2023 09.
Article en En | MEDLINE | ID: mdl-37357529
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma Anaplásico de Células Grandes / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Child / Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma Anaplásico de Células Grandes / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Child / Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido